Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 13:103:adv18472.
doi: 10.2340/actadv.v103.18472.

Efficacy of Oral Alitretinoin in Treatment of Mycosis Fungoides Palmaris et Plantaris

Affiliations

Efficacy of Oral Alitretinoin in Treatment of Mycosis Fungoides Palmaris et Plantaris

Sun Mun Jeong et al. Acta Derm Venereol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
(a, b) Erythematous to brownish hyperkeratotic, fissured, or desquamated patches and plaques on the palms and soles. (Patient numbers 8, 11) (c, d) After 12 weeks of oral alitretinoin treatment, the skin lesions were almost completely improved. (Patient numbers 8, 11).

Similar articles

References

    1. Kim ST, Jeon YS, Sim HJ, Kim SH, Kim YK, Suh KS, et al. . Clinicopathologic features and T-cell receptor gene rearrangement findings of mycosis fungoides palmaris et plantaris. J Am Acad Dermatol 2006; 54: 466–471. - PubMed
    1. Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids. Clin Exp Dermatol 2011; 36: 149–154. - PubMed
    1. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. . Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808–817. - PubMed
    1. Kapser C, Herzinger T, Ruzicka T, Flaig M, Molin S. Treatment of cutaneous T-cell lymphoma with oral alitretinoin. J Eur Acad Dermatol Venereol 2015; 29: 783–788. - PubMed
    1. Alhusayen R, Vu TT, Almuhanna N, Wohlmuth-Wieser I, Hardin J, Hughes JM, et al. . Evaluation of alitretinoin for the treatment of mycosis fungoides and Sézary syndrome. Dermatology 2021; 237: 479–485. - PubMed